Inventor · Munich, DE

Patrick Hoffmann

38Patents
10h-index
55Co-inventors
74Inventor score

Filing activity: Feb 6, 2004 → Sep 20, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US9150664B2 Binding molecules for BCMA and CD3 Chemistry; Metallurgy 54 Active
US9340621B2 Binding molecules for BCMA and CD3 Chemistry; Metallurgy 51 Active
US10294300B2 Antibody constructs for DLL3 and CD3 Chemistry; Metallurgy 28 Active
US8518403B2 Expression-enhanced polypeptides Chemistry; Metallurgy 24 Active
US9587036B2 Cross-species-specific PSMAxCD3 bispecific single chain antibody Chemistry; Metallurgy 23 Active
US9598500B2 Binding molecules for BCMA and CD3 Chemistry; Metallurgy 17 Active
US10301391B2 BCMA and CD3 bispecific T cell engaging antibody constructs Chemistry; Metallurgy 16 Active
US10519241B2 Antibody constructs for EGFRVIII and CD3 Chemistry; Metallurgy 14 Active
US9688760B2 Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains Chemistry; Metallurgy 13 Active
US9765157B2 Antibody constructs for CDH19 and CD3 Chemistry; Metallurgy 10 Active
US10781264B2 PSMA and CD3 bispecific T cell engaging antibody constructs Chemistry; Metallurgy 8 Active
US10059766B2 Antibody constructs for CDH19 and CD3 Chemistry; Metallurgy 7 Active
US10752694B2 Binding molecules for BCMA and CD3 Chemistry; Metallurgy 5 Active
US10683351B2 Antibody constructs for DLL3 and CD3 Chemistry; Metallurgy 4 Active
US10766969B2 Binding molecules for BCMA and CD3 Chemistry; Metallurgy 4 Active
US11434302B2 Bispecific T cell engaging antibody constructs Chemistry; Metallurgy 4 Active
US11084876B2 Anti-leukocyte adhesion for the mitigation of potential adverse events caused by CD3-specific binding domains Physics 3 Active
US9486475B2 PPS for the prevention of potential adverse effects caused by CD3 specific binding domains Human Necessities 3 Active
US11591396B2 Antibody constructs for DLL3 and CD3 Chemistry; Metallurgy 3 Active
US11447567B2 Antibody constructs for FLT3 and CD3 Chemistry; Metallurgy 2 Active
US11472886B2 Cross-species-specific PSMAxCD3 bispecific single chain antibody Chemistry; Metallurgy 2 Active
US10851170B2 Antibody constructs for CD70 and CD3 Chemistry; Metallurgy 2 Active
US11352433B2 BCMA and CD3 bispecific T cell engaging antibody constructs Chemistry; Metallurgy 1 Active
US11661462B2 Optimized cross-species specific bispecific single chain antibody contructs Chemistry; Metallurgy 1 Active
US11155629B2 Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3 Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.